
Oracle Rises, Nike Continues Fall, BioMarin Up Big After Acquisition
Stock Movers
00:00
BioMarin to acquire Amicus
Emily reports BioMarin's agreement to buy Amicus to expand rare-disease treatments, sending both stocks higher.
Play episode from 04:06
Transcript


